1. DIPG-27. OPTIMIZING CLINICAL TRIAL DESIGN: PHARMACOKINETICS OF MARIZOMIB AND PANOBINOSTAT IN A NON-HUMAN PRIMATE MODEL. (23rd April 2019) Authors: Warren, Katherine; Shankarappa, Priya; Peer, Cody; Garcia, Rafael Cruz; Monje-Deisseroth, Michelle; Figg, W Doug; McCully, Cynthia Lester Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 2 Page Start: ii74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EPCT-09. CNS LEVELS OF PANOBINOSTAT IN A NON-HUMAN PRIMATE MODEL: COMPARISON OF BLOOD AND CEREBROSPINAL FLUID PHARMACOKINETIC METHODS AND MALDI MSI. (1st June 2021) Authors: Warren, Katherine; McCully, Cynthia Lester; Garcia, Rafael Cruz; Stopka, Sylwia; Regan, Michael; Aye, Thet; Zimmerman, Sara; Peer, Cody; Kramer, Josh; Breed, Matthew; Figg, W Douglas; Agar, Nathalie Journal: Neuro-oncology Issue: Volume 23(2021)Supplement 1 Page Start: i48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EXTH-100. EVALUATION OF PANOBINOSTAT PLASMA AND CEREBROSPINAL FLUID (CSF) PHARMACOKINETIC PROFILE FOLLOWING ADMINISTRATION OF THE CAPSULE FORMULATION FARYDAK® IN A NON-HUMAN (NHP) PRIMATE PRECLINICAL MODEL. (14th November 2022) Authors: McCully, Cynthia Lester; Warren, Katherine; Zimmerman, Sara; Peer, Cody; Killoran, Kristin; Garcia, Rafael Cruz; Figg, William; Widemann, Brigitte Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EXTH-102. PLASMA AND CEREBROSPINAL FLUID (CSF) PHARMACOKINETICS (PK) OF MIRDAMETINIB IN A NON-HUMAN PRIMATE (NHP) MODEL. (14th November 2022) Authors: McCully, Cynthia Lester; Shearer, Todd; Gross, Andrea; Langseth, Abraham; Peer, Cody; Killoran, Kristin; Garcia, Rafael Cruz; Figg, William; Widemann, Brigitte Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EXTH-57. PLASMA AND CEREBROSPINAL FLUID PHARMACOKINETICS OF THE PROCASPASE-ACTIVATING COMPOUND, PAC-1, FOLLOWING ORAL ADMINISTRATION IN A NON-HUMAN PRIMATE MODEL. (5th November 2018) Authors: McCully, Cynthia Lester; Cruz, Rafael; Lyubimov, Alexander V; Zakharov, Alexander D; Fischer, James H; Hergenrother, Paul J; Warren, Katherine E Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EXTH-64. COMPARISON OF PANOBINOSTAT CSF PENETRATION WITH CNS PENETRATION FOLLOWING SYSTEMIC ADMINISTRATION IN A PRE-CLINICAL NON-HUMAN PRIMATE MODEL. (12th November 2021) Authors: McCully, Cynthia Lester; Warren, Katherine; Zimmerman, Sara; Peer, Cody; Rafael, Cruz Garcia; Kramer, Joshua; Breed, Matthew; Figg, William Douglas; Agar, Nathalie; Widemann, Brigitte Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗